March 22, 2018 / 6:24 AM / a year ago

Medical devices maker Medartis prices Swiss IPO at 48 francs/share

FILE PHOTO: A logo of Medartis, a Swiss producer of metal implants for the surgical management of fractures, is seen during a news conference to present the planned IPO, in Zurich, Switzerland March 12, 2018. REUTERS/Moritz Hager

ZURICH (Reuters) - Swiss medical devices maker Medartis MED.S priced its initial public offering at 48 Swiss francs ($50.61) per share, implying a market capitalization of 563 million francs and a free float of 24.6 percent including over-allotment shares, it said on Thursday.

That was in the middle of the indicated price range of 44 to 54 francs per share for the deal in which Zuercher Kantonalbank [ZKB.UL] and Bryan, Garnier & Co are joint global coordinators and joint bookrunners for Medartis, while Kepler Cheuvreux is acting as co-manager. Quarton International is acting as financial adviser.

Gross proceeds of 123.9 million francs, or 142.6 million including the over-allotment shares, will be used to finance the company’s strategic growth, it added in a statement.

Trading on the SIX Swiss exchange begins on Friday.

Reporting by Michael Shields

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below